Company / R&D per Share
Bausch & Lomb Corp R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.05
FY2025
5-year range
$0.77 / $1.05
FY2021-FY2025
Trend
+7.4%
vs FY2024
Sector context
#67 of 103
Health Care
What the data says
At $1.05, Bausch & Lomb Corp's r&d per share ranks #67 of 103 in the Health Care sector. R&D per Share has increased for 5 consecutive years, from $0.72 in FY2020 to $1.05 in FY2025.
Based on SEC 10-K filings.
1.05 in FY2025 with a 5-year CAGR of +7.8%.
Improved from $0.93 to $1.05 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
#67 of 103 in Health CareTop 65% of 103This company $1.05 Sector average $2.13
▼
-50.6% below sector average
Key checks
Key Insights
- Bausch & Lomb Corp's r&d per share has grown for 5 consecutive years.
- In FY2025, r&d per share increased 7.4% year-over-year.
- Ranks #67 out of 103 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | +7.4% |
| FY2024 | $0.98 | +5.9% |
| FY2023 | $0.93 | +5.5% |
| FY2022 | $0.88 | +13.3% |
| FY2021 | $0.77 | +7.1% |
| FY2020 | $0.72 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026